Friday - January 16, 2026

Category Archives: Pharmaceuticals & Biotech

Liver Cirrhosis Clinical Trials Analysis: 30+ Companies, 30+ Therapies, and 10 Key Clinical Breakthroughs Shaping the Market, analyses DelveInsight

Liver Cirrhosis Clinical Trials Prominent liver cirrhosis developers include Sagimet Biosciences, Gwo Xi Stem Cell Applied Technology, AstraZeneca, Galectin Therapeutics, Vedanta Biosciences, Resolution Therapeutics, Mirum Pharmaceuticals, TenNor Therapeutics, Prism Pharma, Ipsen, Versantis AG, Lipocine, among others. (Albany, USA) DelveInsight’s “Liver … Continue reading →

Fabry Disease Market Valued at USD 1.7 Billion in 2024, According to DelveInsight

Fabry Disease Market Key companies active in the Fabry Disease space include Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, and CellGenTech. DelveInsight … Continue reading →

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Antisense Oligonucleotide Therapeutics Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 90+ pipeline drugs in the Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the Antisense Oligonucleotide Therapeutics pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Autoimmune Encephalitis Market Size in the 7MM is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Autoimmune Encephalitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Autoimmune Encephalitis, historical and forecasted epidemiology as well as the Autoimmune Encephalitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

Herpes Zoster Market Size in the 7MM is projected to increase at a significantly CAGR by 2034, estimates DelveInsight

DelveInsight’s “Herpes Zoster Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Herpes Zoster, historical and forecasted epidemiology as well as the Herpes Zoster market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

Hemophilia A Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight

DelveInsight’s, “Hemophilia A Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Hemophilia A pipeline landscape. It covers the Hemophilia A pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Congenital Adrenal Hyperplasia Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight| Becton, Dickinson and Company, Cook Medical, Cooper Surgical, Smiths Medi

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards developing 8+ Congenital Adrenal Hyperplasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Acute Pancreatitis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Dynavax Tech, Fresenius SE, GlaxoSmithKline, Abbott, B. Braun SE

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Pancreatitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Acute Pancreatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Spinal Muscular Atrophy Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc., Ionis Pharma, Genzyme

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Malignant Ascites Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Malignant Ascites Pipeline Insights 2026” Report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Malignant Ascites pipeline landscape. It covers the Malignant Ascites pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →